Clinical Trials List
2021-09-01 - 2022-04-12
Phase II/III
Terminated5
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 楊家瑞 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳宣鋒 Division of Thoracic Medicine
- 賴建豪 Division of Thoracic Medicine
- Hsien Hung Cheng Division of Emergency Medicine
- 蔡孟耘 Division of Thoracic Medicine
- Chun-Yu Lin Division of Infectious Disease
- 李穗豪 Division of Thoracic Medicine
- 戴千翔 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wang-Huei Sheng Division of Infectious Disease
- 詹尚易 Division of Infectious Disease
- 劉旺達 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih Hsueh Lin Division of Family Medicine
- Ho Mao-Wang Division of Infectious Disease
- 鄭宜昌 Division of Emergency Medicine
- Yu-Chao Lin Division of Thoracic Medicine
- 許原山 Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
245 participants
-
Global
2634 participants
